Titanium Platelet-rich Fibrin in Sinus Floor Elevation Through Flapless Transcrestal Approach
- Conditions
- Sinus Floor Elevation
- Interventions
- Other: Flapless transcrestal sinus lift approach with TPRFOther: Flapless transcrestal sinus lift approach with PRF
- Registration Number
- NCT05721612
- Lead Sponsor
- Hams Hamed Abdelrahman
- Brief Summary
Dental implant therapy in the posterior maxilla may be difficult owing to limited bone height after dental extraction with sinus pneumatization. Several approaches for sinus floor elevation have been documented, and hence flapless transcrestal sinus floor elevation is minimally invasive technique which is used in moderately defected maxilla.
Aim of the study: to evaluate both clinical and radiographic outcomes in sinus floor elevation following dental implant placement using flapless transcrestal sinus lift approach with Titanium platelet rich fibrin (TPRF) as a sole sinus graft material compared to Platelet rich fibrin (PRF).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 16
- Patient seeking replacement of a missed maxillary posterior teeth by a delayed dental implant procedure.
- Residual bone height is (4-7) mm measured from crestal bone to sinus floor.
- Good oral hygiene
- Uncontrolled Diabetes.
- Coagulation disorders.
- Immunological disorders.
- Previous radiation of the head and neck region.
- Abnormal bone physiology.
- Therapy with Bisphosphonates.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Study group Flapless transcrestal sinus lift approach with TPRF - Control gorup Flapless transcrestal sinus lift approach with PRF -
- Primary Outcome Measures
Name Time Method Change in bone density Baseline and 6 months Cuts of CBCT (cross sectional, axial and sagittal view), bone density, will be analyzed using On-demand software. The radiographic evaluation will be based on radiological parameters, using reference points and lines at T0 and T1.
- Secondary Outcome Measures
Name Time Method Change in implant stability Baseline and 6 months Secondary implant stability will be measured 6 months post-operatively using Osstell device.
change in pain scores 1st day, 3rd day and 1 week Pain (by Visual Analogous Scale) ranges from 0 to 10 0 - No pain. 2 to 4 - Mild pain. 5 to 7 - Moderate pain. 8 to 10 - severe pain.
Trial Locations
- Locations (1)
Alexandria Faculty of Dentistry
🇪🇬Alexandria, Egypt